![Dennis Purcell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dennis Purcell
Chairman at
SOLVONIS THERAPEUTICS PLC
Net worth: 92 479 $ as of 30/06/2026
Profile
Dennis Joseph Purcell is the founder of Aisling Capital LLC, founded in 1998, serving as Senior Advisor.
Current jobs include Non-Executive Chairman at Solvonis Therapeutics Plc since 2024; Director at Rosetta Capital Ltd. since 2017; Director at Real Endpoints LLC; Independent Director and Advisor at Bioscience Managers Pty Ltd. since 2003; Chief Operating Officer & Director at Summus Global, Inc.; Non-Executive Director at Ichnos Glenmark Innovation, Inc.; and Advisor at The New York City Investment Fund Manager, Inc. Former jobs include Special Advisor to the CEO at Awakn Life Sciences Corp.; Executive Chairman at Poliwogg Holdings, Inc.; Director at Valentis, Inc., Paratek Pharmaceuticals, Inc. (2009–2012), Cengent Therapeutics, Inc., Bridge Pharmaceuticals, Inc., Biotechnology Innovation Organization, Embera NeuroTherapeutics, Inc., Dynova Laboratories, Inc., Aton Pharma, Inc., Xanodyne Pharmaceuticals, Inc., New York Biotechnology Association, Inc., The Irvington Institute for Immunological Research, ViralClear Pharmaceuticals, Inc., and Harvard Medical School (Member); Managing Director at PaineWebber, Inc.; and Managing Director at Chase H&Q (1995–1998).
Education includes an MBA from Harvard University and undergraduate studies at the University of Delaware.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/05/2025 | 3,98,61,638 ( 0.59% ) | 92 479 $ | 30/06/2026 |
Dennis Purcell active positions
| Companies | Position | Start |
|---|---|---|
| SOLVONIS THERAPEUTICS PLC | Chairman | 26/09/2024 |
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Founder | 01/01/1998 |
The New York City Investment Fund Manager, Inc.
 The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager invests in the companies located in the United States. The firm focuses on fintech, health IT, life sciences and advanced manufacturing sectors. It participates in early and growth stage capital transactions. The firm acquires minority interest. | Consultant / Advisor | - |
Real Endpoints LLC
 Real Endpoints LLC Data Processing ServicesTechnology Services Provides information and analytics services | Director/Board Member | - |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Director/Board Member | 01/01/2003 |
Summus Global, Inc.
 Summus Global, Inc. Internet Software/ServicesTechnology Services Operates as virtual healthcare platform | Chief Operating Officer | - |
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Director/Board Member | - |
Rosetta Capital Ltd.
 Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital invests in early and mid-stage growth companies in biotechnology-related sectors. The firm invest in acquisition financing and spin-off transactions. | Private Equity Investor | 30/10/2017 |
Former positions of Dennis Purcell
| Companies | Position | End |
|---|---|---|
Chase H&Q
 Chase H&Q Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 31/12/1998 |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Dennis Purcell
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
40
1st degree connections
27
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 27 |
|---|---|
Valentis, Inc.
 Valentis, Inc. Pharmaceuticals: MajorHealth Technology Develops products for urology indications | Health Technology |
Paratek Pharmaceuticals, Inc. /Old/
 Paratek Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative solutions for patients with infectious diseases | Health Technology |
Cengent Therapeutics, Inc.
 Cengent Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Researches & develops pharmaceutical drugs | Commercial Services |
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Finance |
Bridge Pharmaceuticals, Inc.
 Bridge Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research services to the pharmaceutical industry | Commercial Services |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Embera NeuroTherapeutics, Inc.
 Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for smoking cessation, cocaine dependence and other addictions | Health Technology |
Dynova Laboratories, Inc.
 Dynova Laboratories, Inc. Food RetailRetail Trade Develops and markets natural healthcare products and supplements | Retail Trade |
Poliwogg Holdings, Inc.
 Poliwogg Holdings, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PaineWebber, Inc.
 PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services | Finance |
Aton Pharma, Inc.
 Aton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical therapeutics for cancer and other diseases | Health Technology |
Chase H&Q
Chase H&Q Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xanodyne Pharmaceuticals, Inc.
 Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
The New York City Investment Fund Manager, Inc.
The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager invests in the companies located in the United States. The firm focuses on fintech, health IT, life sciences and advanced manufacturing sectors. It participates in early and growth stage capital transactions. The firm acquires minority interest. | Finance |
Rosetta Capital Ltd.
Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital invests in early and mid-stage growth companies in biotechnology-related sectors. The firm invest in acquisition financing and spin-off transactions. | Finance |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes the biotechnology industry | Commercial Services |
The Irvington Institute for Immunological Research
 The Irvington Institute for Immunological Research Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Real Endpoints LLC
Real Endpoints LLC Data Processing ServicesTechnology Services Provides information and analytics services | Technology Services |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Summus Global, Inc.
Summus Global, Inc. Internet Software/ServicesTechnology Services Operates as virtual healthcare platform | Technology Services |
Graft Polymer (UK) Plc
 Graft Polymer (UK) Plc Miscellaneous ManufacturingProducer Manufacturing Develops polymer modification technologies | Producer Manufacturing |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
Viralclear Pharmaceuticals, Inc.
 Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to fight SARS-CoV-2 virus that causes COVID-19 | Health Technology |
Awakn Life Sciences Corp.
 Awakn Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides psychedelic assisted psychotherapy solutions | Health Services |
- Stock Market
- Insiders
- Dennis Purcell
